Finding new ways for the P. falciparum malaria parasite to invade red blood cells

Malaria kills almost one million people every year. The symptoms include fever, anemia and sometimes death. P. falciparum is the parasite that is responsible for most of the deaths. It is a major contribution to children?s high morbidity and mortality in countries like Uganda. There is no vaccine and resistance against medications is an increasing problem. The parasites live inside erythrocytes where they multiply, and every 48 hours new mini-parasites, so called merozoites, exit the bursting old erythrocytes and enter new erythrocytes. We want to study the process of invasion into new erythrocytes. If we know exactly which proteins the merozoites bind to, we can use this in creating a vaccine or in forming new drugs. We will use combinations of parasites with defined invasion pathways or merozoite antigen knock-out parasites together with erythrocytes that lack specific antigens on their surface, or antibodies against these antigens. We will combine our own expertise of malaria with our collaborator?s expertise in erythrocyte variants, and we believe that this can create totally new opportunities to find new ways of invasion for the P. falciparum parasites. This knowledge is urgently needed to be able to make a vaccine against malaria.

Project ID
SE-0-29-2014-4286-285-12262
Activity status
2 - Implementation
Aid type
D02 - Other technical assistance
% to Uganda
100.00

Organisations

Funding
Sweden
Implementing
Lunds universitet
Extending
None

Disbursements by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Uganda Value (USD)
2017 Q2 28,782.03 28,782.03
2016 Q2 28,165.72 28,165.72
2015 Q2 31,199.74 31,199.74

Commitments by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Uganda Value (USD)
2014 Q3 88,975.36 88,975.36

MTEF projections by fiscal year

Fiscal year Value (USD) Uganda Value (USD)

CRS code %
Malaria control (12262) 100.0